Dr. Vanderpool is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
705 Riley Hospital Dr
Roc 4210
Indianapolis, IN 46202Phone+1 317-944-3774Fax+1 317-944-8521- Is this information wrong?
Summary
- Dr. Charles Vanderpool, based in Indianapolis, specializes in Pediatric Gastroenterology with subspecialties in Intestinal Rehabilitation, Small Bowel Transplantation, and Pediatric Nutrition. He received his medical degree from Indiana University School of Medicine in 2005 and completed his residency and fellowship in Pediatrics and Pediatric Gastroenterology, respectively, at Vanderbilt University Medical Center. Dr. Vanderpool's experience includes managing short bowel syndrome, intestinal failure, and pediatric feeding disorders. He has made considerable contributions to medical literature with several publications in prestigious journals. His research work includes a long-term safety study of Teduglutide in pediatric participants with Short Bowel Syndrome. In 2021, he was recognized by the American Society for Enteral and Parenteral Nutrition with the Pediatric Nutrition Assessment Competition Award.
Education & Training
- Vanderbilt University Medical CenterFellowship, Pediatric Gastroenterology, 2008 - 2011
- Vanderbilt University Medical CenterResidency, Pediatrics, 2005 - 2008
- Indiana University School of MedicineClass of 2005
Certifications & Licensure
- IN State Medical License 2011 - 2025
- TN State Medical License 2008 - 2011
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
Awards, Honors, & Recognition
- Pediatric Nutrition Assessment Competition at Malnutrition Awareness Week American Society for Enteral and Parenteral Nutrition (ASPEN), 2021
Clinical Trials
- Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS) Start of enrollment: 2017 Jan 09
Publications & Presentations
PubMed
- 99 citationsOutcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel SyndromeBeth A. Carter, Valeria C. Cohran, Conrad R. Cole, Mark R. Corkins, Reed A. Dimmitt
The Journal of Pediatrics. 2017-02-01 - 205 citationsMechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.Charles Vanderpool, Fang Yan, D. Brent Polk
Inflammatory Bowel Diseases. 2008-11-01 - 34 citationsIntrahepatic bile duct regeneration in mice does not require Hnf6 or Notch signaling through Rbpj.Teagan J. Walter, Charles Vanderpool, Ashley Cast, Stacey S. Huppert
The American Journal of Pathology. 2014-05-01
Hospital Affiliations
- Indiana University Health North HospitalCarmel, Indiana
- Indiana University Health University HospitalIndianapolis, Indiana
- Riley Hospital for Children at IU HealthIndianapolis, Indiana
- Riley Hospital for Children at IU Health North HospitalCarmel, Indiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: